Apotea
62.23 SEK
-0.43 %
Less than 1K followers
APOTEA
NASDAQ Stockholm
Personal Goods
Consumer Goods & Services
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Apotea
| 2024 | 2025 | |
|---|---|---|
| Revenue | 6,541.1 | 7,203.3 |
| growth-% | 10.1 % | |
| EBITDA | 395.4 | 460.5 |
| EBIT | 265.8 | 298.2 |
| Profit before taxes | 264.7 | 289.9 |
| Net income | 212.0 | 225.4 |
| EPS | 2.09 | 2.20 |
| Dividend | 0.00 | 0.60 |
| Dividend ratio | 0.0 % | 27.3 % |
Profitability and return on capital
| 2024 | 2025 | |
|---|---|---|
| EBITDA-% | 6.0 % | 6.4 % |
| EBIT-% | 4.1 % | 4.1 % |
| ROE | 33.3 % | 26.2 % |
| ROI | 13.0 % | 11.4 % |